The high-profile obesity drug developer priced the biotech sector’s biggest offering since 2022 and will use the proceeds to ...
In this article, we will be taking a look at the 10 Best Biotech Stocks Under $10 to Buy. According to Eli Casdin, CEO of ...
This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent ...
InvestorsHub on MSN
Novartis agrees to acquire US biotech company Excellergy in deal worth up to $2 billion
Swiss pharmaceutical group Novartis (NYSE:NVS) announced on Friday that it has reached an agreement to acquire California-based biotechnology company Excellergy in a transaction valued at up to $2 ...
Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ('Alterity” or 'the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
Dozens of Massachusetts workers are about to lose their jobs after the FDA rejected a promising cancer drug — for the second ...
Focused on infectious disease therapies, this biotech firm reported a notable insider sale amid a year of strong share price gains.
In February, a small biotech company reached a breakthrough with the FDA, agreeing to a clinical trial plan. The problem: The ...
Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results